Kelechi Onyekwere, | |
1155 Dairy Ashford Rd Ste 560, Houston, TX 77079-3035 | |
(832) 388-6552 | |
Not Available |
Full Name | Kelechi Onyekwere |
---|---|
Gender | Female |
Speciality | Licensed Vocational Nurse |
Location | 1155 Dairy Ashford Rd Ste 560, Houston, Texas |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1033752126 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
164X00000X | Licensed Vocational Nurse | 350965 (Texas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Kelechi Onyekwere, 1155 Dairy Ashford Rd Ste 560, Houston, TX 77079-3035 Ph: () - | Kelechi Onyekwere, 1155 Dairy Ashford Rd Ste 560, Houston, TX 77079-3035 Ph: (832) 388-6552 |
News Archive
NovaBay Pharmaceuticals, Inc. a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, delivered two poster presentations on its compounds at the 48th Annual Meeting of the Infectious Diseases Society of America (IDSA) in Vancouver, Canada.
Patients often complain that getting a good night's sleep or a bit of peace and quiet in hospital can be difficult. But a study published in the December issue of the Journal of Clinical Nursing has shown that adopting some simple measures can reduce peak noise levels on hospital wards by just under 20 per cent.
Using clever chemistry, a Scripps Research team has pinpointed the enzyme target of a drug group that stops the progression of the devastating disease Friedreich's ataxia in mice and may do the same for humans. The findings, developed in collaboration with scientists from Repligen Corporation, help advance this treatment approach one step closer toward human clinical trials, which will be a welcome event for disease sufferers who currently have few treatment options.
Within the UK there are several centres whose nurse specialists work to a best practice model, delivering care and achieving outcomes which are extremely high in areas of patient retention, adherence to medication and completion of the treatment regimen. With this they achieve cure rates which are some of the highest in the World.
Access Pharmaceuticals, Inc., today announced it has initiated a Phase I/II dose-escalating study of its proprietary, anti-cancer drug, Thiarabine, a nucleoside analog for patients with hematologic malignancies (cancers of the blood). The primary objective of the study is to determine the maximum tolerated dose (MTD) in two different dosing schedules with various leukemias and lymphomas and recommended Phase II dose. The program is being led by Hagop Kantarjian, M.D., Chair of the Department of Leukemia at The University of Texas MD Anderson Cancer Center in Houston, Texas.
› Verified 1 days ago
Rose Alozie, Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 9950 Town Park Dr Apt 205, Houston, TX 77036 Phone: 713-666-8287 | |
Chidimma Muonaka, Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 1155 Dairy Ashford Rd Ste 560, Houston, TX 77079 Phone: 713-799-2200 | |
Tina Hudson, Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 1155 Dairy Ashford Rd Ste 209, Houston, TX 77079 Phone: 713-799-2200 | |
Kendra Burrell, Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 1155 Dairy Ashford Rd, Houston, TX 77079 Phone: 713-799-2200 | |
Ms. Lou Etta Culpepper, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 6607 Glen Rock Dr, Houston, TX 77087 Phone: 713-643-3076 Fax: 281-489-6009 | |
Amalu Nwasokwa, Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 2424 Wilcrest Dr Ste 110, Houston, TX 77042 Phone: 832-416-5853 | |
Bridget Kirksey, Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 1155 Dairy Ashford Rd Ste 209, Houston, TX 77079 Phone: 713-799-2200 |